|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 33 of 35 found articles
| Title: |
The FDA-approved compound, pramipexole and the clinical-stage investigational drug, dexpramipexole, reverse chronic allodynia from sciatic nerve damage in mice, and alter IL-1β and IL-10 expression from immune cell culture |
| Author: |
Sanchez, J.E. Noor, S. Sun, M.S. Zimmerly, J. Pasmay, A. Sanchez, J.J. Vanderwall, A.G. Haynes, M.K. Sklar, L.A. Escalona, P.R. Milligan, E.D. |
| Appeared in: |
Neuroscience letters |
| Paging: | Volume 814 () nr. C pages p. |
| Year: |
2023 |
| Contents: | |
| Publisher: |
The Authors |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 33 of 35 found articles
| << previous | next >> |